1. Integrated breast-conserving plastic surgery and repair with precise classification and treatment
High rate of breast-conserving surgery, integrated plastic and reconstructive surgery, and precise treatment based on breast type. Early-stage breast cancer can be treated with breast-conserving radical mastectomy and breast reconstruction simultaneously, avoiding the trauma of total mastectomy.
2. Advanced minimally invasive surgery to achieve precise breast preservation.
For refractory subtypes such as triple-negative breast cancer and HER2-positive breast cancer, we have extensive experience in combined immunotherapy and targeted therapy. Our recurrence control rate and long-term survival rate are comparable to those of top hospitals in Europe and America, and our treatment efficacy is on par with the world's top standards .
3. Overall costs are significantly lower than in Europe and America, with no hidden fees.
China has widely adopted proton and heavy ion therapy and robotic minimally invasive surgery with no hidden fees, significantly reducing the cost of treating serious illnesses . Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.
4. Zero waiting period, rapid medical intervention to avoid delays in treatment.
In Europe, America, Japan, and South Korea, the waiting time for specialist appointments and surgeries at public hospitals is generally 3-12 months, while private institutions are extremely expensive and still have a waiting period of 1-3 months. China has a well-established international medical channel, and breast cancer patients who come to China for medical tourism through Trisana Medguide can have an in-person consultation within 3 days and start treatment within 7 days, allowing for early admission and early recovery and preventing delays in treatment .
